NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
NCT Number: NCT02983513
Preterm infants, during their stay in the Neonatal Intensive Care Unit (NICU), face a period of stressful environment, which may negatively impact early brain development and subsequent neurobehavioral outcomes. This study aims to assess the effectiveness of training parents in reducing stressful experiences early in life and in enhancing brain development and long term developmental outcomes.
Looking for future studies?
Notify Me25 week–29 week
All sexes
Interventional
Not applicable
Milan, 20122, Italy
Very preterm birth is associated with motor, cognitive and behavioral problems.
Micro-structural brain abnormalities, even in the absence of focal lesions, have been documented by neuroimaging studies in preterm infants at term corrected age and later in childhood. These alterations in brain maturation occurring during the neonatal period may be implicated in long-term neurobehavioral disorders later experienced by preterm babies.
However, there is increasing evidence that also negative environmental factors (intensive care, excessive sensory stimulation, paucity of parental contact etc.) can affect later outcomes.
Potential benefits of early dyadic interaction and preterm baby massage in reducing the effects of the NICU stressor environment have been demonstrated. More recently, few studies have investigated visual function in preterm infants focusing on the potential role of early visual interaction to enhance attention and improve later neurodevelopment.
The role of early intervention strategies to improve neurodevelopment has been recently emphasized.
Early intervention programs based on the concept of "individualized care" have proved to be effective in promoting brain maturation and neurodevelopmental outcome. In this context, early interventions as the Mother Infant Transaction Program (MITP) and the Premie Start, both targeting parenting, have the greatest potential to have sustained effects on child development.
In addition, recent studies have shown that exposure to stressful events in the neonatal period can cause epigenetic modifications in children born preterm; in particular alteration of serotonergic tone was observed, associated with methylation of the serotonin transporter gene, which could be implicated in the etiology of behavioral disorders observed in these children. In animal models these epigenetic effects appear to be influenced by maternal care that can epigenetically modulate the offsprings' stress response.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mothers are selected according to the following inclusion criteria: age over 18 years, good comprehension of Italian language, no obvious cognitive impairments or psychiatric disorders, no drug addiction and no single-parent families.
Time frame: 40 weeks postmenstrual age
Neonatal Visual Function is assessed using the Visual Assessment Battery developed by Ricci et al. The assessment evaluates the following items: Ocular spontaneous motility, ability to fix and follow a target, reaction to colour, visual acuity and visual attention at distance. Each item is scored as normal (score 0) or abnormal (score 1). The global score is then calculated as the sum of all the individual items, as designed by the authors.
Time frame: 2 months corrected age
Neonatal behavior is assessed using the Neonatal Behavior Assessment Scale that evaluates: habituation, social-interactive, motor system, state organization and regulation, autonomic system, reflexes.
Time frame: 40 weeks postmenstrual age
Conventional and advanced MRI
Time frame: 24 months corrected age
Children development is assessed using the Bayley Scales of Infant and Toddlers (Third edition) - including: cognitive, motor, language, social-emotional and adaptive behavior)
Time frame: up to 48 weeks gestational age
epigenetic analysis is performed at birth on a cord blood sample (0.5 ml) and at hospital discharge on a peripheral blood sample (0.5 ml) collected according routine clinical procedures
Time frame: up to 48 weeks gestational age
number of days from admission to home discharge from NICU
Time frame: 40 week gestational age
Time frame: 40 week gestational age
Time frame: 40 week gestational age
Time frame: up to 48 weeks gestational age
Postmenstrual age at the acquisition of full oral feeding
Time frame: up to 40 weeks gestational age
Feeding with human milk at 40 weeks postmenstrual age (yes or no)
Time frame: 5-6 years of age
Children neurodevelopment is assessed using the Griffiths Development Scales (GMDS).
Scores range from 50 to 150 General quotient mean 100 SD 12, sub scales mean 100 SD 16 Higher scores mean a better outcome
Time frame: 5-6 years of age
Children behavior is assessed using the Child Behavior Checklist. A T score above 70 is considered to be in the clinical range, a T score between 65 an 70 is considered borderline while a T score below 65 is considered normal
Time frame: 5-6 years of age
Children neuromotor is assessed using the Movement Assessment Battery for Children (Movement ABC).
A score above 67 is considered to be in the normal range, a score between 57 an 67 is considered borderline while a score below 56 is considered pathological
Time frame: 5-6 years of age
Child attention abilities is assessed using the Early Childhood Attention Battery (ECAB).
Scaled scores range from 1 to 19. Lower scores indicate worst outcome
Time frame: 5-6 years of age
epigenetic analysis - L1 promoter methylation (Percent) assessment is performed on a buccal swab collected at follow-up assessment at 5-6 years.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Other
Early Intervention in Preterm Infants: Effects of a Parental Training Program on Neonatal Brain Development, Visual Functions and Neurobehavioral Outcome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718516
Body Weight, Body Weight Changes
New York, United States
View Trial DetailsNCT03673709
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Blantyre, Malawi
View Trial DetailsNCT07693530
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07661511
Female Urogenital Diseases and Pregnancy Complications, Hypothermia Neonatal
Querétaro, Mexico
View Trial Details